Helomics is a clinical contract research organization. It utilizes a tumor drug response profiling platform to generate a roadmap helping oncologists personalize the patient’s treatment.

Employee Rating

2.6More
TypeSubsidiary
Parent CompanyPredictive Oncology
Websitehelomics.com
Cybersecurity ratingBMore

Viewing summary data as a guest

Sign up for free to see all data

Helomics Financials and Metrics

Summary Metrics

In total, Helomics had raised $231.5 m. Helomics is a subsidiary of Predictive Oncology

Helomics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Helomics Online and Social Media Presence

Embed Graph

Helomics News and Updates

Predictive Oncology Announces DojoLIVE! Interview with Helomics CIO Mark Collins, ‘Can We Cure Cancer with Artificial Intelligence?’

LOS ANGELES, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announces that Mark Collins, Ph.D., chief innovation officer of…

Helomics Blogs

Helomics Frequently Asked Questions

  • How many employees does Helomics have?

    Helomics has 83 employees.

  • Who are Helomics competitors?

    Competitors of Helomics include MTM, Datos Health and AHEAD Medicine.